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Background: Allgrove’s 4A syndrome determines ocular surface changes. This is the first report providing an
up-to-dated analysis of the ocular surface in an affected patient.
Case presentation: An 18-years-old male Caucasian patient, with a complex progressive gait disorder and adrenal
insufficiency, was referred for ophthalmic evaluation, as part of the clinical assessment. He underwent the following
tests: best corrected visual acuity, tear osmolarity, tear film break-up time (BUT), corneal fluorescein staining, Schirmer’s I
test, lid margin assessment, corneal sensitivity, in vivo corneal confocal microscopy, conjunctival impression cytology,
tonometry and fundus exam. A dry eye condition was documented by the Schirmer’s I test of 0 mm/5’ in both eyes,
accompanied by tear hyperosmolarity, mild meibomian gland dysfunction, reduced BUT, mucus filaments in the tear
film and conjunctival epithelium metaplasic changes. The corneal confocal microscopy showed the presence of
activated keratocytes, while the nerve pattern was normal.
Conclusions: The dry eye in this patient appears to be due to tear aqueous deficiency and can be considered as part
of the 4A syndrome. The decreased tear production, resulting from a deterioration of the autonomic innervation of the
lacrimal glands rather than an impaired corneal innervation, can be considered as part of the systemic autonomic
dysfunction present in this disease.
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Tear functionBackground
Allgrove syndrome, or triple A, is a clinical entity charac-
terized by the association of deficient cortisol secretion,
with elevated plasma corticotrophin, achalasia of the
cardia and defective or absent tear production [1]. A
disturbance of ATP/cyclic AMP metabolism of the
adrenal glands, leading to autonomic symptoms, was
proposed. Allgrove syndrome was entered in the Online
Mendelian Inheritance in Man compendium with the
number #231550. The association of the triple A syn-
drome with autonomic and peripheral neuropathies
was termed as 4A syndrome [2].
Even if alacrima is the most constant symptom (75%
of the patients) [3], thus indicating an important ocular* Correspondence: paragona@unime.it
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unless otherwise stated.surface involvement, previous ophthalmological investi-
gations were limited to the fundus exam, Schirmer’s I
test and slit lamp examination of the ocular surface. The
fundus exam evidenced a bilateral nerve head pallor [4],
the Schirmer’s I test showed reduced or minimal [5] tear
secretion, and a punctate keratopathy was often observed
[6]. However, no data are available, as far as we know,
about the exact ocular surface features, which may
guide appropriate diagnosis and treatment in a clinical
setting [7].
We report the ocular surface features including also
tear osmolarity, in vivo corneal confocal microscopy and
conjunctival impression cytology, to obtain clinical infor-
mation useful to demonstrate and follow up ocular sur-
face alterations in a patient with 4A syndrome.
Case presentation
The patient, an 18 years old Caucasian boy, is the second
child of consanguineous parents (second degree cousins).l. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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7 years, when he developed progressive gait, running
disturbances and difficulties in playing soccer. At the age
of 9.7 years, he experienced a severe ketotic, hypoglycemic
attack. At the age of 10 years, due to the progressive wors-
ening of the neurological symptoms, he was referred to
the Unit of Neurology of the University of Messina, where
a complex picture of upper and lower motor neuron
involvement was recognized. Magnetic resonance imaging
of the brain and cervical spinal cord was normal. On that
occasion, the presence of marked skin pigmentation and
brown spots of the tongue, together with a clinical history
positive for ketotic hypoglycemia, suggested the diagnosis
of adrenal insufficiency. This clinical suspicion was con-
firmed by a typical hormonal profile with very high ACTH
levels and undetectable levels of cortisol, both basal and
stimulated by i.v. ACTH. Further investigations showed
an autonomic dysfunction with postural hypotension and
abnormal heart reflexes. The oral treatment with hydro-
cortisone, at substitutive doses (10 mg/m2/day), caused a
significant improvement of the patient’s general well
being, although ACTH levels remained elevated. The
coexistence of ACTH-resistant adrenal insufficiency and
neurological manifestations suggested the hypothesis of
triple A syndrome, that was confirmed by DNA analysis
of the AAAS gene. In fact, sequencing the coding regions
and exon/intron junctions of this gene identified a homo-
zygous splice mutation in intron 14. This is a G >AFigure 1 Confocal microscopy of the cornea. A. The subbasal nerves (N
stroma, keratocytes (k) show morphological features typical of activated ce
processes and well evident nuclei. D. Endothelial cells (E) are normal. Scalereplacement at the first nucleotide in intron 14, resulting
in aberrant splicing (IVS14 + 1G >A). As expected, the
parents were both heterozygous carriers of the mutation,
as well as the two clinically healthy siblings [8].
During the clinical assessment, an ophthalmologic exam
was performed, because the patient referred of symptoms
characterized by foreign body sensation and itching, start-
ing in the morning and worsening in the evening, mild
dryness and light sensitivity. Before the clinical exam, an
informed consent was obtained. The clinical procedures
were in accordance with the Declaration of Helsinki.
The ophthalmologic exam included visual acuity as-
sessment, ocular surface study, tonometry, and fundus
examination. For the ocular surface study, the following
tests were performed: tear osmolarity measurement
(TearLab™ Osmolarity System Inc., TearLab™ Corp., San
Diego, CA, USA), slit-lamp examination of the ocular
surface, tear film break-up time (BUT), corneal fluores-
cein staining, Schirmer’s I test (SNO strips, Laboratoire
Chauvin, Aubenas, France), lid margin assessment, cor-
neal sensitivity, in vivo corneal confocal microscopy
(Confoscan 4, Nidek, Vigonza PD, Italy) and conjunctival
impression cytology (Supor 200 membrane filters, Gelman
Sciences, Ann Arbor, MI, USA) [9,10].
The best-corrected visual acuity was 20/20 in both
eyes. Tear osmolarity was 300 mOsm/l in the right eye
(RE) and 332 mOsm/l in the left eye (LE). The slit-lamp
examination showed an unstable tear film with a BUT) present a rectilinear course with some beadings. B. In the anterior
lls. C. In the posterior stroma, keratocytes (k) possess elongated
bar: 50 μm.
Figure 2 Conjunctival impression cytology specimens stained with PAS-Papanicolaou stain. A. In right eye, isolated cells show condensed
nuclear chromatin and mild keratinisation (arrow). B. In the left eye, isolated cells show a metaplasic appearance, pyknotic nuclei with reduced
N/C and highly keratinized cytoplasm (arrow). Scale bar: 40 μm.
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staining was present in the LE conjunctiva in both
interpalpebral areas; no signs of epithelial damage were
present in the RE. A mild papillary hypertrophy was
present in the upper tarsal conjunctiva in both eyes.
Schirmer’s I test was 0 mm/5’ in both eyes. The lid
margins showed a mild hyperemia, with meibomian
gland expression giving rise to slightly turbid meibum.
The keratoaesthesiometry was within normal values
(RE = 1.08 g/mm2; LE = 0.96 g/mm2). In both eyes, the
corneal confocal microscopy showed normal epithelial
features. The subbasal corneal nerves presented a rectilin-
ear course, with occasional beadings (Figure 1A). Stromal
keratocytes, either in the anterior (Figure 1B) or in the
posterior stroma (Figure 1C), showed morphological
features typical of activated cells. Endothelial cells were
normal (Figure 1D). The conjunctival impression cytology
showed in RE the presence of islands of bilayered epithe-
lial cells, together with areas of isolated cells. The cells
within the bilayered tissue appeared of normal size, with
N/C of 1:1 or 1:2. Also the isolated cells showed a normal
N/C, although cells with reduced N/C could be seldom
observed. Nuclear chromatin showed a condensed appear-
ance. Goblet cells were normally represented. A mild
keratinisation was present in some cells (Figure 2A). The
LE showed the presence of islands of bilayered cells,
together with areas of isolated and highly keratinized
cells with a metaplasic appearance and pyknotic nuclei.
Particularly in the isolated cells, the N/C was reduced
(Figure 2B). In the multilayered areas some goblet cells
were observed. The intraocular pressure was 14 mmHg in
both eyes. The fundus exam was normal in both eyes.
Conclusions
4A syndrome, a rare disease, is characterized by an auto-
nomic disturbance, which is usually demonstrated by per-
ipheral motor and sensory neuropathy, involving several
organs. Although one of the more frequent dysfunctionsof this syndrome is the alacrima, its pathogenic mechan-
ism is still not clear [3]. In fact, due to the lack of in
depth studies, it is not known whether the ocular surface
damages derive either from a systemic autonomic dysfunc-
tion of the lacrimal gland or from primarily altered ocular
surface structures leading to a lacrimal gland impairment.
In our patient, we found a markedly decreased tear pro-
duction, as demonstrated by Schirmer’s I test, which was
accompanied by increased tear osmolarity, metaplasic
conjunctival changes and corneal keratocytes activation,
in presence of normal corneal nerves and aesthesiometry.
Therefore, it seems that, in our patient, the ocular surface
dysfunction is part of the autonomic disturbance, which
may directly determine a lacrimal gland impairment,
rather than a primary corneal nerve involvement. These
findings suggest that the dry eye present in this patient is
typically of the aqueous deficient type. The lacrimal gland
alterations described elsewhere [4,11] might depend on an
innervation failure, which is always accompanied by gland
atrophy [12]. Therefore, the alacrima demonstrated in
Allgrove syndrome could be considered as a part of a sys-
temic autonomic dysfunction, rather than an independent
topical clinical feature. It could be proposed that the treat-
ment of the ocular surface dysfunction in these patients
should consider, together with topical treatments aimed
to protect the corneal-conjunctival epithelium, also a
systemic approach addressed to improve the lacrimal gland
secretion and correct its neurological dysfunction.Consent
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